Ultragenyx Pharmaceutical | RARE - Debt

Stock Price
23.92
Daily Change
-0.77 -3.12%
Monthly
6.12%
Yearly
-47.75%
Q1 Forecast
23.33

Ultragenyx Pharmaceutical reported $36.3M in Debt for its fiscal quarter ending in June of 2025.





Debt Change Date
Acadia Pharmaceuticals USD 56.29M 1.36M Jun/2025
Agios Pharmaceuticals USD 48.76M 47.62M Jun/2025
Alnylam Pharmaceuticals USD 1.3B 271.5M Jun/2025
BioMarin Pharmaceutical USD 603.87M 8.22M Jun/2025
Insmed USD 564.56M 464K Sep/2025
Ionis Pharmaceuticals USD 1.23B 192.99M Sep/2025
Kyowa Hakko Kirin JPY 28.75B 5.04B Dec/2024
MacroGenics USD 37.01M 238K Sep/2025
Moderna USD 741M 4M Jun/2025
Neurocrine Biosciences USD 439.1M 8.4M Jun/2025
PTC Therapeutics USD 286.32M 306K Sep/2025
Regeneron Pharmaceuticals USD 2.71B 400K Sep/2025
Sarepta Therapeutics USD 1.35B 215.59M Jun/2025
Ultragenyx Pharmaceutical USD 36.3M 1.98M Jun/2025
Vertex Pharmaceuticals USD 1.53B 121.7M Jun/2025